Novo Nordisk A/S Rises On Unusually High Volume (NVO)

Novo Nordisk A/S (NYSE:NVO) is trading at unusually high volume Monday with 634,686 shares changing hands. It is currently at 2.4 times its average daily volume and trading up $3.11 (+2%).
By TheStreet Wire ,

NEW YORK (

TheStreet

) --

Novo Nordisk A/S

(NYSE:

NVO

) is trading at unusually high volume Monday with 634,686 shares changing hands. It is currently at 2.4 times its average daily volume and trading up $3.11 (+2%) at $158.08 as of 10:25 a.m. ET.

  • EXCLUSIVE OFFER: Jim Cramer's Protégé, Dave Peltier, only buys Stocks Under $10 that he thinks could potentially double. See what he's trading today with a 14-day FREE pass.

Novo Nordisk A/S has a market cap of $86.9 billion and is part of the health care sector and drugs industry. Shares are down 5% year to date as of the close of trading on Friday.

Novo Nordisk A/S engages in the discovery, development, manufacture, and marketing of pharmaceutical products primarily in Denmark. It operates in two segments, Diabetes Care and Biopharmaceuticals. The company has a P/E ratio of four, below the S&P 500 P/E ratio of 17.7.

TheStreet Ratings rates

Novo Nordisk A/S

as a

buy

. The company's strengths can be seen in multiple areas, such as its impressive record of earnings per share growth, compelling growth in net income, revenue growth, notable return on equity and expanding profit margins. We feel these strengths outweigh the fact that the company shows weak operating cash flow. You can view the full

Novo Nordisk A/S Ratings Report

.

See all heavy volume stocks in our

stocks moving on unusual volume list

or get investment ideas from our

investment research center

.

3x UPSIDE POTENTIAL: TheStreet Quant Ratings has identified a handful of stocks that can potentially TRIPLE in the next 12-months. Learn more.

.

null

Loading ...